Docosanol Patent Expiration
Docosanol is Used for treating cold sores and fever blisters on the face or lips by shortening healing time and reducing symptoms. It was first introduced by Haleon Us Holdings Llc
Docosanol Patents
Given below is the list of patents protecting Docosanol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Abreva | US4874794 | Inflammatory disease treatment |
Apr 28, 2014
(Expired) | Haleon Us Holdings |
| Abreva | US5534554 | Sucrose ester-C20 to C28 alcohol formulations |
Dec 13, 2013
(Expired) | Haleon Us Holdings |
Docosanol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List